1544P Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations

Abstract

Conclusions: Patients with primary Kaposi sarcoma experience a 7.4% increased risk of SPNs compared to the RP. Patients 25-29 years old at time of diagnosis display the highest risk of SPNs. Around 2 to 11 months after Kaposi sarcoma diagnosis mark an increased risk of Non-Hodgkin lymphoma development. Male Kaposi sarcoma patients tend to be more at risk to develop malignancies than the RP. Patients who are diagnosed with primary Kaposi sarcoma should be followed with these risks in mind.Legal entity responsible for the study: The authors.